Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus MR in Stable Pediatric Liver Transplant Patients
NCT00282256Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Jan 2004
- Primary completion
- Oct 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of tacrolimus + Wuzhi capsule in Liver transplant rejection, sponsored by Astellas Pharma. Started Jan 2004; status: completed.
02
Drugs
tacrolimus + Wuzhi capsule
03
Conditions
Liver transplant rejection
Beyond the preview
Go deeper on NCT00282256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00282256.